Mitsui & Co. Global Investment
Profile, fund size and portfolio
Mitsui & Co. Global Investment is the corporate venture arm of Mitsui & Co., Ltd. (general trading company). It was founded in 2001 and is based in Menlo Park, United States. It invests from Seed to Series A in healthcare AI, biotech and therapeutics, climate tech.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series A |
| Sectors | Healthcare AI, Biotech and therapeutics, Climate tech, Enterprise software and data |
| Geography | Global |
| Offices | Menlo Park, United States, Tokyo, Japan |
Sources: S11 BioSpace: Waypoint Bio raises $20M Series A led by Amplify Partners; S9 Mitsui Global Investment: Yukitaka Kojima; S1 Mitsui Global Investment home (100+ portfolio, 35+ exits).
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Exited | 30 | 56.6% |
| Active | 23 | 43.4% |
Status as the firm tags it
Sources: S5 Mitsui Global Investment Our Portfolio (Wayback 18 Jul 2024 capture; live page lists more).
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | Not disclosed by the firm. | |||
| Companies backed | 100+ | companies | Stated by the firm | S1 |
| Exits | 35+ | exits | Stated by the firm | S1 |
| Companies on the firm's portfolio page | 53 | companies | Counted from the firm's own list | S5 |
Sources: S1 Mitsui Global Investment home (100+ portfolio, 35+ exits); S5 Mitsui Global Investment Our Portfolio (Wayback 18 Jul 2024 capture; live page lists more).
Where it invests and who leads it
Geography
- Headquarters
- Menlo Park, United States
- Offices
- Menlo Park, United States
- Tokyo, Japan
Investment regionsS11S9S1
- Global
LeadersS3S9S7S8
- Kenjiro (Ken) WatanabePresident & CEOLinkedInFirm page
- Yukitaka Kojima, CFAPrincipalFind on LinkedInFirm page
- Toshihiro TeradaPrincipalFind on LinkedInFirm page
- Kazufumi NakamuraInvestment DirectorFind on LinkedInFirm page
- Reiko Namikawa, MD PhDVenture PartnerFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Mitsui & Co., Ltd. | Single source | S2 |
| Parent industry | General trading company | Single source | S10 |
| Founded | 2001 | Single source | S2 |
| Headquarters | Menlo Park, United States | Single source | S4 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S2 |
| Companies backed | 100+ | Single source | S1 |
| Exits | 35+ total | Single source | S1 |
| People on the team page | 13 | Single source | S3 |
| Stages | Seed, Series A (inferred from announced rounds) | Estimate | S11 |
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
| Company | Type | Year | Acquirer or exchange | Price | Source |
|---|---|---|---|---|---|
| QD Laser | IPO | S5 | |||
| RallyBio | IPO | S5 | |||
| ArmaGen Technologies, Inc. | Acquisition | S5 | |||
| Actimis Pharmaceuticals | Acquisition | S5 | |||
| SBio | Acquisition | S5 | |||
| Sirrus | Acquisition | S5 | |||
| Leyou | Acquisition | S5 | |||
| Cipia | IPO | S5 | |||
| NxThera | Acquisition | S5 | |||
| Six Rooms Holdings | Acquisition | S5 | |||
| goBalto | Acquisition | S5 | |||
| Change Healthcare | Acquisition | S5 | |||
| Marrone Bio Innovations | IPO | S5 | |||
| Glamour Sales | Acquisition | S5 | |||
| Kaltura | IPO | S5 |
Portfolio
The firm's portfolio page lists 53 companies: 23 active, 30 exited.S5
The firm also states 100+ companies backed. The page list and the stated total measure different things.S1
| Tag | Companies | Share |
|---|---|---|
| Active | 23 | 43.4% |
| Exited | 30 | 56.6% |
Every company on the Mitsui & Co. Global Investment list
53 companies, as listed on the firm's own website: 30 exited, 23 active.S5 Read the firm's list.
Exited 30
- Actimis Pharmaceuticals
- ArmaGen Technologies, Inc.
- Beceem Communications
- Bioelectron Technology Corp.
- Boston Biomedical, Inc.
- Change Healthcare
- Cipia
- Convenient Power
- Etonenet
- Glamour Sales
- goBalto
- Hainan Hailing Pharmeceutical
- IAT Automobile Technology
- Kaltura
- Leyou
- Marrone Bio Innovations
- MC10, Inc.
- NxThera
- Protein Simple
- Proterra
- QD Laser
- RallyBio
- Redwood Systems
- Ruckus
- SBio
- Sirrus
- Six Rooms Holdings
- Spire
- Valens
- Virident
Active 23
- Autotalks
- Bionova Pharma
- ContinuumRx
- Ellipsis Health
- Ensem Therapeutics
- GoSecure
- Halation
- Leash Laboratories
- NapaJen Pharma
- Neura Health
- On-chip Biotechnologies
- OpenX
- Pica8
- Pinnacle Engines
- QurAlis
- Reunion Neuroscience
- Rhino Federated Computing
- Silk
- Stately Bio
- Svante
- Symic Biomedical
- Tacit Therapeutics
- Waypoint Bio
For founders
| Item | What the firm says | Source |
|---|---|---|
| Stages | Seed, Series A. Inferred from announced rounds; the firm does not state a range. | S11 |
| MGIcontactSJFVZ@mitsui.com | S4 |
History
- Mitsui & Co. Venture Partners, Inc. established in New York City.S2
- Silicon Valley office opened.S2
- Team members sent to Beijing.S2
- Silicon Valley office becomes headquarters.S2
- Renamed Mitsui & Co. Global Investment.S2
- Investment team built in Israel.S2
- Magenta Venture Partners established.S2
- E12 Ventures established.S2
Where sources disagree
Official pages
Read the firm's own pages for current information.
Sources
- S1Mitsui Global Investment home (100+ portfolio, 35+ exits)Firm
- S2Mitsui Global Investment About Us (timeline)Firm
- S3Mitsui Global Investment Our TeamFirm
- S4Mitsui Global Investment Contact UsFirm
- S5Mitsui Global Investment Our Portfolio (Wayback 18 Jul 2024 capture; live page lists more)Firm
- S6Mitsui Global Investment Our Portfolio (live)Firm
- S7Mitsui Global Investment: Toshihiro TeradaFirm
- S8Mitsui Global Investment: Reiko NamikawaFirm
- S9Mitsui Global Investment: Yukitaka KojimaFirm
- S10Mitsui & Co.: Mitsui Invests in E12 Ventures (2023)Parent company
- S11BioSpace: Waypoint Bio raises $20M Series A led by Amplify PartnersPortfolio company
- S12LinkedIn post by Mitsui & Co. Global Investment on Stately Bio seed roundFirm
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Mitsui & Co. Global Investment or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.